Combining nilotinib and PD-L1 blockade reverses CD4+ T-cell dysfunction and prevents relapse in acute B-cell leukemia

Sean I. Tracy, Hrishi Venkatesh, Can Hekim, Lynn M. Heltemes-Harris, Todd P. Knutson, Veronika Bachanova, Michael A. Farrar

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Combining nilotinib and PD-L1 blockade reverses CD4+ T-cell dysfunction and prevents relapse in acute B-cell leukemia'. Together they form a unique fingerprint.

Medicine and Dentistry